培美曲塞联合奥沙利铂与吉西他滨联合奥沙利铂治疗老年晚期肺腺癌(3)
 |
| 第1页 |
参见附件。
[3] 吕梅君，施海燕，李爱武，等.老年肺癌370例非手术治疗临床资料分析[J].中华医学研究杂志，2004，4(10)：878-880.
[4] Lilenbaum RC,Herndon JE,List MA,et al.Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer:the cancer and leukemia group B(study 9730)[J]. J Clin ONCOL,2005,23(1):190-196.
[5] Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].N Engl J Med,2002,346(2): 92-98.
[6] 孙燕，石远凯.临床肿瘤内科手册[M].第5版.北京：人民卫生出版社，2007：840-846.
[7] Hanna N,Shepherd FA,Fossella FV,et al.Randomized phaseⅢ trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy[J]. J Clin Oncol,2004,22(9):1589-1597.
[8] Gridelli C,Kaukel E,Gregorc V,et al.Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy:a multicenter,randomized,phaseⅡ trial[J]. J Thorac Oncol,2007,2(3):221-229.
[9] Scagliotti GV,Parikh P,Von pawel J,et al.PhaseⅢ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[J].J Clin Oncol,2008,26(21): 3543-3551.
[10] MonnetⅠ, Brienza S,Hugret F,et al.PhaseⅡ study of oxaliplatin in poor-prognosis non-small cell lung cancer(NSCLC)ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques[J].Eur J Cancer,1998,34(7): 1124-1127.
[11] 李之曦，侯梅，王海燕，等.吉西他滨联合奥沙利铂或顺铂一线治疗老年晚期非小细胞肺癌的随机研究[J].中国肺癌杂志，2011，14(7)：588-592.
[12] 朱海生，严浩林，谭丽萍，等.培美曲塞治疗34例老年晚期非小细胞肺癌的疗效分析[J].广西医学，2011，33(8)：1023-1025.
(收稿日期：2011-11-21)
您现在查看是摘要介绍页，详见PDF附件。